Tenax Therapeutics, Inc. TENX
Set alert
At close · Oct 30
After hours · Oct 30, 7:59 PM ET
- YTD
- -85.32%
- 1 year
- -76.04%
- Open
- 1.83
- Prev close
- 1.86
- Mkt cap
- 66.99M
- Vol
- 888.06K
- Avg vol
- 5.69M
- EPS
- -1.48
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.73
- High
- 1.85
- Forward P/E
- -1.06
- Beta
- 2.15
- Short ratio
- 1.46
- Inst. own
- 47.95%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 1, 2024
- 50-d avg
- 4.96
- 200-d avg
- 3.94
- 1y target
- 16.30
5D chart
Signals (59)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 3:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:05 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:10 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 11:45 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:50 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 2 days ago |
| RSI: Oversold | Oct 29, 2:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:00 PM | 3 days ago |
| RSI: Oversold | Oct 29, 1:35 PM | 3 days ago |
| RSI: Oversold | Oct 29, 12:50 PM | 3 days ago |
| RSI: Oversold | Oct 29, 12:30 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:55 AM | 3 days ago |
| RSI: Overbought | Oct 29, 11:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:20 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:45 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:35 AM | 3 days ago |
| RSI: Overbought | Oct 29, 10:10 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:30 PM | 4 days ago |
| RSI: Overbought | Oct 28, 12:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:20 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:20 PM | 4 days ago |
| RSI: Overbought | Oct 28, 11:25 AM | 4 days ago |
| RSI: Overbought | Oct 28, 10:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:15 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:55 AM | 4 days ago |
| SMA: Bearish | Oct 27, 3:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:05 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:50 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:50 PM | 6 days ago |
| RSI: Oversold | Oct 26, 3:40 PM | 6 days ago |
| RSI: Oversold | Oct 26, 2:55 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:40 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:25 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:10 PM | 6 days ago |
News
3 hours ago newsfilecorp.com
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
New York, New York--(Newsfile Corp. - November 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax…
8 hours ago prnewswire.com
TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline
SAN DIEGO, Nov. 1, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tenax Therapeutics, Inc. (NASDAQ: TENX) securities between November…
11 hours ago globenewswire.com
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Lead Plaintiff Deadline: December 28, 2026. Investors who purchased (NASDAQ: TENX) securities between November 13, 2023 and August 7, 2026 may be eligible to recover losses.
12 hours ago globenewswire.com
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
NEW YORK, Nov. 01, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax Therapeutics, Inc.…
1 day ago newsfilecorp.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
New York, New York--(Newsfile Corp. - October 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax…
1 day ago newsfilecorp.com
TENX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Tenax Therapeutics (TENX) Investors of Securities Class Action Lawsuit Deadline on December 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Tenax To Contact Him Directly To Discuss Their Options If you purchased or acquired…
2 days ago globenewswire.com
TENX Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Tenax Therapeutics, Inc. Class Action Lawsuit
SAN DIEGO, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise…
2 days ago newsfilecorp.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
New York, New York--(Newsfile Corp. - October 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax…
2 days ago prnewswire.com
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) -- Investors Who Suffered Losses Are Encouraged to Contact the Firm.
Lead Plaintiff Deadline: December 28, 2026. Investors who purchased (NASDAQ: TENX) securities between November 13, 2023 and August 7, 2026 may be eligible to recover losses.
2 days ago businesswire.com
Lost Money on Tenax Therapeutics, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 89.77% Share Price Drop
LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Tenax Therapeutics, Inc. ("Tenax" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP…
2 days ago prnewswire.com
ATTENTION NASDAQ: TENX INVESTORS: Contact Berger Montague About a Tenax Therapeutics, Inc. Class Action Lawsuit
PHILADELPHIA, Oct. 30, 2026 /PRNewswire/ -- Berger Montague, a leading national plaintiffs' law firm, announces a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ: TENX) ("Tenax" or the…
2 days ago businesswire.com
Did You Lose Money on Tenax Therapeutics, Inc. Stock? The Law Offices of Howard G.
BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Tenax Therapeutics, Inc. ("Tenax" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith…
3 days ago newsfilecorp.com
Kaplan Fox Encourages Tenax Therapeutics, Inc. (TENX) Investors with Significant Losses to Contact the Firm Before December 28, 2026
New York, New York--(Newsfile Corp. - October 29, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company")…
3 days ago businesswire.com
TENX INVESTOR DEADLINE: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)---- $TENX #TENX--The case alleges that Tenax Therapeutics and its executives made false and/or misleading statements to investors.
3 days ago newsfilecorp.com
TENX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Tenax Therapeutics (TENX) Investors of Securities Class Action Lawsuit Deadline on December 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Tenax To Contact Him Directly To Discuss Their Options If you purchased or acquired…
3 days ago globenewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax Therapeutics, Inc.…
3 days ago newsfilecorp.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
New York, New York--(Newsfile Corp. - October 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax…
3 days ago businesswire.com
Lost Money on Tenax Therapeutics, Inc. Shares? The Law Offices of Frank R.
LOS ANGELES--(BUSINESS WIRE)--Tenax Therapeutics, Inc. ("Tenax" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it…
3 days ago newsfilecorp.com
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (TENX) - Investors Who Suffered Losses Are Encouraged to Contact the Firm
Lead Plaintiff Deadline: December 28, 2026. Investors who purchased (NASDAQ: TENX) securities between November 13, 2023 and August 7, 2026 may be eligible to recover losses.
3 days ago newsfilecorp.com
Berger Montague PC Investigating Claims on Behalf of Investors in Tenax Therapeutics, Inc. (TENX) After Class Action Filing
Philadelphia, Pennsylvania--(Newsfile Corp. - October 29, 2026) - Berger Montague, a leading national plaintiffs' law firm, announces a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ:…
3 days ago prnewswire.com
TENX Shareholder Alert: December 28, 2026 Lead Plaintiff Deadline in Tenax Therapeutics, Inc. Securities Class Action - Contact SueWallSt
Executive Accountability: Chief Medical Officer Stuart Rich is named in the Tenax securities action over his alleged assurances that the Phase 3 LEVEL study of TNX-103 was enriched with the patients…
3 days ago prnewswire.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers - TENX
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) and certain…
4 days ago prnewswire.com
TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, Oct. 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax Therapeutics, Inc.…
4 days ago newsfilecorp.com
TENX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Tenax Therapeutics (TENX) Investors of Securities Class Action Lawsuit Deadline on December 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Tenax To Contact Him Directly To Discuss Their Options If you purchased or acquired…
4 days ago gurufocus.com
Rosen Law Firm Urges Tenax Therapeutics, Inc. (NASDAQ: TENX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) bet
4 days ago businesswire.com
Rosen Law Firm Urges Tenax Therapeutics, Inc. (NASDAQ: TENX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between…
4 days ago globenewswire.com
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Lead Plaintiff Deadline: December 28, 2026. Investors who purchased (NASDAQ: TENX) securities between November 13, 2023 and August 7, 2026 may be eligible to recover losses.
4 days ago globenewswire.com
Tenax Therapeutics, Inc. (NASDAQ: TENX) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Tenax Therapeutics, Inc. Securities Lawsuit - Contact Portnoy Law Firm
LOS ANGELES, Oct. 28, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in Tenax Therapeutics, Inc. (NASDAQ: TENX) that a securities class action lawsuit has been filed on behalf of…
5 days ago prnewswire.com
TENX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Tenax Therapeutics, Inc.
SAN DIEGO, Oct. 27, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise…
5 days ago globenewswire.com
TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead the Tenax Therapeutics Class Action Lawsuit – RGRD Law
SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tenax Therapeutics, Inc. (NASDAQ: TENX) securities between November 13, 2023…
5 days ago globenewswire.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers – TENX
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) and certain…
5 days ago newsfilecorp.com
Kaplan Fox & Kilsheimer LLP Alerts Tenax Therapeutics, Inc. (TENX) Investors to a Securities Class Action Deadline on December 28, 2026
New York, New York--(Newsfile Corp. - October 27, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company")…
5 days ago globenewswire.com
TENX INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Tenax Therapeutics, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm
ATLANTA, Oct. 27, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Tenax Therapeutics, Inc. (“Tenax”) (NASDAQ: TENX). The lawsuit alleges that Defendants made false…
5 days ago gurufocus.com
Investor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action Lawsuit
Shareholder rights law firm [url="]Robbins LLP[/url] informs investors that a class action was filed on behalf of all persons and entities who purchased or othe
5 days ago businesswire.com
Investor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)---- $TENX #TENX--The complaint alleges that Tenax Therapeutics, Inc. misled investors regarding the viability of its drug candidate levosimendan.
1 week ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST) stock rose 8.9% to $0.57 during Wednesday's after-market session. The market value of their outstanding shares is at $10.1 million. Tenax Therapeutics…
2 months ago benzinga.com
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month
U.S. stocks settled lower on Monday, with the Dow Jones index falling more than 350 points during the session. Renewed US-Iran strikes over the weekend sent crude sharply higher Monday, reviving…
2 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regular session. The company's market cap stands at $4.0 million. CollPlant Biotechnologies (NASDAQ:CLGN)…
2 months ago benzinga.com
This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings…
-
2 months ago benzinga.com
Reported Earlier, Tenax Reports New Phase 3 Data Supporting TNX-103 In Pulmonary Hypertension Patients
Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax" or "Tenax Therapeutics" or the "Company") today announced that additional results from the Phase 3 LEVEL clinical trial evaluating TNX-103 (oral
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2…
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.2 million. Biodexa…
-
2 months ago benzinga.com
Chardan Capital Downgrades Tenax Therapeutics to Neutral, Lowers Price Target to $5
Chardan Capital analyst Gautam Chukka downgrades Tenax Therapeutics (NASDAQ:TENX) from Buy to Neutral and lowers the price target from $27 to $5.
-
2 months ago benzinga.com
Guggenheim Maintains Buy on Tenax Therapeutics, Lowers Price Target to $4
Guggenheim analyst Seamus Fernandez maintains Tenax Therapeutics (NASDAQ:TENX) with a Buy and lowers the price target from $40 to $4.
-
2 months ago benzinga.com
Evercore ISI Group Downgrades Tenax Therapeutics to In-Line, Lowers Price Target to $5
Evercore ISI Group analyst Gavin Clark-Gartner downgrades Tenax Therapeutics (NASDAQ:TENX) from Outperform to In-Line and lowers the price target from $39 to $5.
2 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regular session. The market value of their outstanding shares is at $16.8 million. As per the press release,…
2 months ago benzinga.com
Crude Oil Surges 3%; Sionna Therapeutics Shares Plunge
US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National Energy Services up 16% on strong earnings.
2 months ago benzinga.com
Tenax Therapeutics Stock Dives as It Faces Heart Drug Study Setback
Tenax Therapeutics announced Phase 3 LEVEL trial results for TNX-103, missing primary endpoints while showing subgroup benefits.
2 months ago benzinga.com
US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results
Dow Jones fell 0.2% as US stocks opened lower. Energy shares rose 1.9%, while real estate stocks dropped 0.9%. Monday.com shares fell 10%.
2 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-market session. The company's market cap stands at $16.8 million. As per the news, the H1 earnings report…